CNS stimulants
medical conditions

CNS stimulants

Explore the available health information, treatment context, and integrative evidence for CNS stimulants.

Background
  • Central nervous system (CNS) stimulants, also called psychomotor stimulants or uppers, are a class of drugs that speed up physical and mental processes. They temporarily make patients feel more alert and improve mood.
  • Stimulants are typically used to treat medical conditions such as attention-deficit hyperactivity disorder (ADHD), attention-deficit disorder (ADD), fatigue, and narcolepsy. Some stimulants have been used as appetite suppressants, although the safety of this use remains controversial.
  • Examples of CNS stimulants include amphetamines, such as methylphenidate (Ritalin®), methamphetamine (e.g. Desoxyn® or Desoxyn Gradumet®), caffeine (e.g. coffee or tea), nicotine (cigarettes or cigars), and the illegal drug cocaine.
  • Side effects of stimulants vary depending on the specific dose and type of drug. In general, side effects of short-term use may include anxiety, insomnia, dry mouth, depersonalization, feeling of euphoria, increased heartbeat, crying, dysphoria, decreased appetite, hyperventilation, irritability, depression, nervousness, paranoia, mood swings, restlessness, and shaking or trembling.
  • Most CNS stimulants are highly addictive. However, some newer drugs, such as modafinil (Provigil®) are less addictive.
  • Because stimulants are highly addictive and have euphoric effects on the brain, they are often abused and taken as recreational drugs. Long-term abuse of stimulants can cause changes in the brain and lead to serious health problems, including severe mental illness and memory loss.
References
  1. Bizarro L, Patel S, Murtagh C, et al. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol. 2004 May;15(3):195-206.
    View Abstract
  2. Dackis CA, Kampman KM, Lynch KG, et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005 Jan;30(1):205-11.
    View Abstract
  3. Goldman LS, Genel M, Bezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998 Apr 8;279(14):1100-7.
    View Abstract
  4. Hickey G, Fricker P. Attention deficit hyperactivity disorder, CNS stimulants and sport. Sports Med. 1999 Jan;27(1):11-21.
    View Abstract
  5. Jordan PS. CNS stimulants sold as amphetamines. Am J Hosp Pharm. 1981 Jan;38(1):29.
    View Abstract
  6. Li M, Wessinger WD, McMillan DE, et al. Effects of amphetamine-CNS depressant combinations and of other CNS stimulants in four-choice drug discriminations. J Exp Anal Behav. 2005 Jul;84(1):77-97.
    View Abstract
  7. Narconon International. . Accessed September 5, 2007.
  8. Narcotics Anonymous (NA). . Accessed September 5, 2007.
  9. National Institutes of Health (NIH). . Accessed September 5, 2007.
  10. Natural Standard: The Authority on Integrative Medicine. . Copyright © 2008. Accessed September 5, 2007.
  11. Substance Abuse & Mental Health Services Administration (SAMHSA). . Accessed September 5, 2007.
  12. Yonkov DI. Correlations between the effects of CNS stimulants on memory processes and open field behavior of rats: the importance of brain cholinergic activity. Methods Find Exp Clin Pharmacol. 1985 Mar;7(3):113-8.
    View Abstract